At an ordinary repeat-prescription review, a pharmacist notices metformin or omeprazole on the medicine list. You have already checked a vitamin B12 product and found no obvious direct interaction warning, so it seems as though the question is settled.
Then the pharmacist asks a few more questions: How long have you taken the medicine? Has the amount changed? Has vitamin B12 ever been checked? Is B12 already included in another supplement?
Direct answer: Some medicines can contribute to lower B12 status without directly interacting with a B12 supplement. Metformin and prolonged use of proton pump inhibitors are common examples worth reviewing. Do not stop the medicine or assume that adding an ordinary retail supplement is the complete answer.
No direct interaction alert does not close the B12 question. A pharmacist, GP, prescriber or treating clinical team can help separate medicine review, testing and treatment from ordinary supplement selection. Changes to prescribed medicine belong with the prescriber.
Separate the three questions
People often treat three different questions as though they were one. Keeping them separate makes the next step safer and clearer.
Question A: Could this medicine affect B12 status over time?
This is mainly an absorption and risk-factor question. It can depend on how long the medicine has been used, the amount taken, diet, age, gastrointestinal conditions, previous stomach or bowel surgery, and other reasons B12 may be harder to obtain or absorb.
A medicine may therefore be relevant to B12 status even when it does not chemically clash with a supplement.
Question B: Does this B12 product directly interact with the medicine?
This is an exact-product and exact-medicine question. The full ingredient list, medicine name, strength, directions and the person’s health conditions all matter.
A general product statement cannot settle every individual situation. A pharmacist can review the complete product and medicine list, including prescribed medicines, over-the-counter products, herbal products and nutrition drinks.
Question C: Is this now a testing or treatment question?
Previous low B12 results, anaemia, neurological concerns, existing B12 injections, clinician-directed high-dose oral B12, or a diagnosed absorption condition move the situation beyond ordinary retail selection.
In these circumstances, the clinician should guide the testing and treatment sequence. An ordinary supplement should not be used as a substitute for that plan.
A yes, no or unknown answer to one question does not automatically answer the others.
Two medicine pathways worth recognising
Pathway 1: Metformin
Metformin may reduce vitamin B12 absorption from the gut in some people. The chance of low B12 becoming relevant can increase with longer use, higher amounts and additional risk factors such as a restricted diet or a condition that affects absorption.
Current New Zealand medicine information recognises B12 monitoring as potentially relevant during ongoing metformin treatment. One current Metformin Viatris data sheet describes checks before treatment, after six months and annually after that. This is information for that product, not a universal schedule for every person or every metformin product. The appropriate review schedule belongs with the treating clinician.
Diabetes symptoms, medicine effects and B12-related concerns may overlap. Tiredness, altered sensation or other changes cannot be diagnosed from an article or symptom list. Do not reduce or stop metformin because you are worried about B12. Metformin has an important role for many people, and its benefits may outweigh its risks.
Pathway 2: Proton pump inhibitors
Proton pump inhibitors, often called PPIs, include omeprazole, lansoprazole and pantoprazole in New Zealand. They reduce the amount of acid made by the stomach.
Stomach acid helps release naturally occurring B12 from food protein. With prolonged acid suppression, this food-bound B12 pathway may work less efficiently for some people. Long-term PPI use is therefore more relevant to a B12 review than a brief ordinary course, but a short course does not prove a B12 problem.
Some people need ongoing PPI treatment because the benefits are greater than the risks. Do not stop a PPI abruptly or change it through a supplement decision. Ask the prescriber or pharmacist whether ongoing use is still appropriate and whether B12 review makes sense in your circumstances.
Other medicines: Other medicines may be relevant in individual cases, but this is not a medicine-interaction database. Take the exact medicine name, strength and directions to a pharmacist or clinician rather than relying on a generic list.
Build the medicine-duration timeline
This timeline is a record for a conversation, not a score. It does not tell you what a blood result means or whether treatment is needed.
Before the medicine
- Was B12 ever checked?
- Were diet or absorption risks already present?
- Was a B12 supplement already being used?
When the medicine began
- Record the reason for the medicine.
- Record the starting amount.
- Note the expected duration, if this was discussed.
During ongoing use
- Record amount changes and other medicines added.
- Note changes in diet or appetite.
- Record new gastrointestinal conditions.
- Include stomach or bowel surgery.
- Add new supplements containing B12.
Current review
- Is B12 already inside a multivitamin, B complex, brain formula or nutrition drink?
- Has a clinician suggested testing?
- Are there new, persistent or neurological concerns?
- Is the medicine still needed in its current form?
Last known B12 information
- Record the result and date, if known.
- Write unknown or never checked when that is the honest answer.
- Record any existing prescribed treatment.
The supplement-first trap
Buying a B12 supplement can feel like a simple fix, but it may be the wrong first move when deficiency is suspected.
1. Testing may need to come first
Starting B12 replacement can affect how later test results are interpreted. Ask the clinician ordering the test whether blood should be taken before you start. Do not stop an existing supplement unless that clinician tells you to, and do not delay urgent assessment or treatment while waiting for a routine test.
2. The cause still matters
Medicine use, diet, pernicious anaemia, gastrointestinal conditions and surgery can require different responses. Finding the likely cause helps the treating team decide what testing, follow-up and replacement approach is appropriate.
3. Retail nutritional support is not clinical treatment
An ordinary retail product is not automatically equivalent to clinician-directed high-dose oral treatment or B12 injections. A diagnosed deficiency or absorption condition needs a clinical plan.
4. B12 may already be present elsewhere
Check multivitamins, B complexes, brain-support formulas, nutrition drinks and prescribed products. This is a brief overlap check, not a full supplement audit.
Choose the next question
| Situation | Question to take to the review |
|---|---|
| Taking metformin with no known B12 review | Should B12 monitoring be considered in my situation? |
| Taking a PPI long term | Is ongoing use still appropriate, and should B12 status be reviewed? |
| New persistent or neurological concerns | Do I need assessment before starting a supplement? |
| Previous low B12 result | What cause was identified, and what treatment plan should I follow? |
| Already receiving injections or high-dose oral B12 | Should an ordinary retail product be avoided or included? |
| No symptoms, no result and an ordinary nutrition question | Have diet, medicines and existing supplements been reviewed first? |
The Gold Health Two-Question Check: Product Interaction or B12-Status Risk?
Gold Health’s current product page says there are no known drug interactions or contraindications for Activated Vitamin B12. That answers a general product-interaction question. It does not answer whether metformin, a proton pump inhibitor or another medicine may be contributing to lower B12 status, or whether testing and clinician-directed treatment should come before ordinary supplementation.
Question 1: Does this product have a known direct interaction with my medicine?
The current page states that none are known. This is general label information, not an individual pharmacist assessment. It does not confirm suitability for every medicine, health condition or treatment plan. The same page advises people taking medication or managing a health condition to consult a healthcare professional.
Question 2: Could my medicine still affect my B12 status?
The answer may be yes even when no direct product interaction is identified. Metformin and prolonged PPI use may affect B12 status through different pathways. This is a medicine-to-nutrient question rather than necessarily a direct supplement interaction.
What the current 50 mcg formula establishes
- Vitamin B12 as methylcobalamin: 50 mcg
- New Zealand kelp, Ecklonia radiata: 100 mg
- Acacia fibre: 300 mg
- Magnesium stearate: 5 mg
- Direction: one capsule daily
- No artificial colouring, flavouring or preservatives
- Gluten free and peanut free
These details establish the B12 form, the amount per capsule, the one-a-day direction and an ordinary daily nutritional-support role.
What the formula does not establish
- Whether B12 deficiency exists
- Whether testing is needed
- Whether 50 mcg is appropriate treatment
- Whether a medicine should change
- Whether injections or clinician-directed high-dose oral B12 are needed
- Whether you should start before a planned blood test
- Whether B12 is already duplicated elsewhere
For the exact ingredients and current directions, see the exact Activated Vitamin B12 formula. Product information can help with label interpretation, but it cannot diagnose a deficiency or replace a review of your medicine and treatment plan.
Prepare the pharmacist handover card
Fill-in sentence:
I take [exact medicine and strength] for [reason]. I have taken it for [duration]. My current supplements are [list]. My last B12 result was [date and result, or unknown]. I am considering [exact B12 product]. Should B12 be checked before I start, and does this product fit my current plan?
Bring these five details:
- Exact medicine names and strengths
- Duration of use
- Current supplements and nutrition drinks
- Previous B12 results or treatment
- New, persistent or worrying changes
This gives the pharmacist or clinician a useful starting point without creating a medicine stop plan.
Four answers to keep
- No direct interaction alert does not mean the medicine is irrelevant to B12 status.
- Metformin and prolonged PPI use can make B12 review more relevant for some people.
- A medicine should not be stopped or changed through a supplement decision.
- Testing or professional review may be appropriate before choosing a product.
Frequently asked questions
Which medicines can affect vitamin B12?
Metformin and prolonged use of proton pump inhibitors are two well-recognised examples that may affect B12 status. Other medicines can be relevant in individual cases, so take the exact medicine name, strength and directions to a pharmacist or clinician rather than relying on a long generic list.
Can metformin lower vitamin B12?
Yes, metformin may reduce B12 absorption and lower B12 status in some people. Risk can depend on duration, amount and other B12 risk factors, so ask the treating clinician whether monitoring is appropriate rather than using a universal timetable.
Can omeprazole or other proton pump inhibitors affect B12?
Yes, prolonged use of omeprazole, lansoprazole or pantoprazole may make B12 review more relevant for some people. These medicines reduce stomach acid, which helps release naturally occurring B12 from food, but they should not be stopped or changed without professional guidance.
Can I take vitamin B12 with metformin?
A B12 product may have no known direct interaction with metformin, but that does not settle whether you need testing or clinician-directed treatment. Ask a pharmacist to review the exact B12 product, your metformin details, other supplements and your health history.
Can I take vitamin B12 with omeprazole?
A B12 product may have no known direct interaction with omeprazole, but prolonged PPI use can still be relevant to B12 status. Review the exact product and medicine with a pharmacist, and ask whether testing should come before supplementation.
Should I stop a medicine if I am worried about B12?
No, do not stop, reduce, taper or switch a prescribed medicine because of a B12 concern without speaking to the prescriber. The medicine may be providing important benefits, and the clinician can decide whether review, testing or treatment is needed.
Should B12 be tested before starting a supplement?
Testing may need to occur before B12 replacement because supplementation can affect test interpretation. Ask the clinician ordering the test what to do, do not stop an existing supplement unless advised, and do not delay urgent assessment or treatment.
Does Gold Health Activated Vitamin B12 interact with medicines?
The current Gold Health page says there are no known drug interactions or contraindications, but this does not replace a review of the exact medicine, health condition and B12-status question. The page also advises people taking medication or managing a health condition to consult a healthcare professional.
Next steps
For general B12 education, read the broader Gold Health vitamin B12 guide.
Before adding a separate product, check whether B12 is already in a senior multivitamin and review the wider supplement routine.
After testing and medicine questions have been addressed, you can compare Gold Health vitamin B12 support. This collection is for comparing ordinary daily nutritional-support options. It does not replace testing, medicine review or clinician-directed treatment.
References
- Healthify: Vitamin B12
- Healthify: Metformin for diabetes FAQs
- Healthify: Proton pump inhibitors
- Medsafe: Metformin Viatris data sheet
- Health New Zealand: Vitamin B12 deficiency and pernicious anaemia
- NICE: Vitamin B12 deficiency in over 16s
- NIH Office of Dietary Supplements: Vitamin B12 fact sheet for health professionals
This article provides general education only and is not medical advice. Do not change prescribed medicine independently. A pharmacist, GP, prescriber or treating clinical team should guide individual testing, medicine changes and treatment, especially where there are new, persistent, neurological or worrying changes.
